Learn more

ADNAGEN AG

Overview
  • Total Patents
    61
About

ADNAGEN AG has a total of 61 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Germany. Its main competitors in its focus markets biotechnology, measurement and machines are ULTIVUE INC, MURACA PATRICK J and OUSSO CLINICAL DIAGNOSIS CORP.

Patent filings per year

Chart showing ADNAGEN AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Waschuetza Stefanie 28
#2 Krehan Alf-Andreas 21
#3 Albert Winfried 21
#4 Steffens Pia 16
#5 Boecher Oliver 10
#6 Tamak Cengiz 9
#7 Lustig Michael 8
#8 Waschutza Stefanie 8
#9 Hauch Siegfried 7
#10 Zieglschmid Veit 7

Latest patents

Publication Filing date Title
EP2088204A1 Method and kit for diagnosing or controlling the treatment of ovarian cancer
EP2037265A1 Solid phase cell isolation and/or enrichment method
EP1832661A1 Method for the individual staging of tumor diseases
EP1803822A1 Method for the individual characterization of therapeutic target molecules and use thereof
WO2005100401A2 Monoclonal antibodies with specificity for fetal erythroid cells
DE102005013261A1 Reagent and method for preventing time-dependent expression in biological cells
DE10246339A1 Predicting risk, and diagnosis, of chemical-induced disease, e.g. chronic fatigue syndrome, comprises determining allelic status of genes involved in the detoxification process
WO03023060A2 Method and kit for diagnosing or controlling the treatment of breast cancer
EP1409745A2 Method and kit for the diagnosis or treatment control of intestinal carcinoma
DE10240021A1 Generation then amplification of DNA copies, useful in multiplex polymerase chain reactions, using primers with a 5'-tag then amplification with tag-specific primer
WO03018837A2 Method and diagnostic kit for the molecular diagnosis of pharmacologically relevant genes
AU2002304640A1 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
DE10219373A1 Diagnostic kit, useful for assessing a subject's tolerance of drugs, comprises reagents for determining alleles of genes encoding detoxification enzymes
DE10219117C1 Use of lithium dodecyl sulfate for stabilizing RNA in solution, particularly during purification of RNA from cell lysate
DE10159904A1 Oligonucleotide arrangement, method for nucleotide detection and device therefor
AU2002219137A1 Diagnosis kit, dna chip, and methods for diagnosing or supervising the treatment of testicular cancer
DE10143775A1 Selection and determination of specific cells, useful particularly for diagnosis and monitoring of tumors, by antibody-mediated selection then detecting specific mRNA
DE10143776A1 Selection and determination of specific cells, useful particularly for diagnosis and monitoring of tumors, by antibody-mediated selection then detecting specific mRNA
DE10140651A1 Diagnostic kit, useful for assessing a subject's tolerance of drugs, comprises reagents for determining alleles of genes encoding detoxification enzymes
WO0208751A2 Mild enrichment of foetal cells from peripheral blood and use thereof